- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04084691
Capillary Glycerolemia Evolution During Physical Exercise (LSEEGLYCEROL)
Maximum fatty acid oxidation is known to occur at exercise intensities between 45 and 65% VO2max and in the fasting state.
However, the optimal level may depend on various unknown factors. Glycerolemia is a good marker of the fatty acid metabolism but its evolution remains poorly described, maybe due to the difficulty of the measure.
A new device allows an easy measurement of glycerolemia during exercise and could enable personalization strategies to optimize exercise efficacy.
In this study, the investigators plan to test three different exercise types and three different fasting conditions with three replicates each to evaluate the variability of glycerolemia and its evolution during exercise.
Study Overview
Status
Conditions
Detailed Description
The metabolism of mobilized fatty acids as an energy reserve during physical exercise produces glycerol, which makes it a marker of the intensity of lipolysis.
This measurement of the intensity of lipolysis in humans can be carried out according to several methods. Since glycerol is a product of lipolysis, its rate of appearance (Ra) in the blood represents a physical quantity naturally associated with lipolysis activity. Unfortunately, its quantification requires the use of a tracer isotope (deuterated glycerol), which limits its applicability. The alternative is the determination of glycerolemia in the blood or in the interstitial fluid via a microdialysis probe placed in subcutaneous adipose tissue;
Recently, a measuring device has been proposed which makes it possible to measure glycerolemia from capillary blood, in the manner of measuring blood glucose in diabetic patients. This device has the advantage of being used repeatedly after a physical exercise. This flexibility also makes it possible to consider the personalization of the sports program by identifying the circumstances associated with an increase in lipolysis such as the type of meal preceding the exercise or its intensity.
Evidence suggests that moderate-intensity exercise (about 45% -65% VO2max) performed under fasting conditions maximizes lipid metabolism as a source of energy, compared with carbohydrate metabolism. But these data conceal a likely significant variability in individual outcomes, including levels of training, gender, age, and nutritional intake prior to exercise. Our hypothesis is that the current recommendation to the diabetic patient, or with a metabolic syndrome, to exercise moderate intensity fasting physical activity could be adapted individually to each patient in order to optimize the benefits of such a practice. In this sense, the easy access to a measurement of capillary glycerolemia could make it possible to identify in a personalized way the type of physical activity.
This research project aims to accurately describe the evolution of capillary glycerolemia in several configurations of physical exercise (variable intensity) by controlling the effect of the previous meal. It will also seek to identify situations associated with a greater increase in capillary glycerolemia to pave the way for personalization of the sports activity program.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75018
- Hopital Bichat Claude-Bernard
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria :
- Major patients followed in Diabetology-Nutrition Day Hospital of Bichat-Claude Bernard Hospital as part of the ETAPES program
- overweight or obese patient: body mass index BMI> 25 kg / m²
- Volunteer to participate in and follow a proposed physical activity program as part of regular follow-up
- Volunteer to participate in the research, comfortable with the use of the device of auto measurement of capillary glycerolemia
Exclusion criteria :
- Pregnancy in progress or breastfeeding
- Patient under guardianship or curatorship
- Patient participating in another interventional research protocol
- No affiliation to the social security scheme or French Universal Health Cover (CMU)
- Absence of informed consent, written and signed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single Arm
Every patient will undergo every combination of physical exercise/meal type (3x3 combinations), one following the other.
Each combination is replicated three times.
|
standardized physical activity (moderate intensity) lasting 30 minutes and having a warm-up portion of 5 minutes
standardized physical activity (high intensity) lasting 30 minutes and having a warm-up portion of 5 minutes
standardized physical activity (bodybuilding) lasting 30 minutes and having a warm-up portion of 5 minutes
- Hyperlipidic meal Energy supply: 800 kcal Distribution of macronutrients: proteins: 15% +/- 5; carbohydrates: 40% +/- 5; lipids: 45 +/- 5 Choice of foods determined with the dietician taking into account the patient's tastes and products available on the market The same meal will be taken before the 3 sessions concerned.
- Hyperglucidic meal Energy supply: 800 kcal Macronutrient distribution: protein 15% +/- 5; carbohydrates 60% +/- 5; lipids 25 +/- 2 Choice of foods determined with the dietician taking into account the patient's tastes and products available on the market. The same meal will be taken before the 3 sessions concerned.
non meal in the hour before exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
concentration of glycerol in capillary blood
Time Frame: at the beginning of exercise
|
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
|
at the beginning of exercise
|
concentration of glycerol in capillary blood
Time Frame: 20 minutes after the beginning of exercise
|
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
|
20 minutes after the beginning of exercise
|
concentration of glycerol in capillary blood
Time Frame: 30 minutes after the beginning of exercise
|
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
|
30 minutes after the beginning of exercise
|
concentration of glycerol in capillary blood
Time Frame: 45 minutes after the beginning of exercise
|
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
|
45 minutes after the beginning of exercise
|
concentration of glycerol in capillary blood
Time Frame: 60 minutes after the beginning of exercise
|
The primary endpoint is the time series of measurements of capillary glycerol concentration using the DietSee device (LSEE, Ajaccio, France)
|
60 minutes after the beginning of exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
1. Maximum concentration of glycerol in capillary blood
Time Frame: from the beginning of the exercise and during one hour
|
Maximum capillary glycerolemia (peak) among the time series
|
from the beginning of the exercise and during one hour
|
2. Glycerol concentration in peripheral venous blood,
Time Frame: 30 minutes after the beginning of bodybuilding exercise (i.e. at the end of the exercice)
|
Glycerolemia in peripheral venous blood, measured at the end of a bodybuilding type exercise session
|
30 minutes after the beginning of bodybuilding exercise (i.e. at the end of the exercice)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Boris HANSEL, MD PHD, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 190089 - IDRCB 2019-A00200-57
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
Universitaet InnsbruckRecruiting
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
Clinical Trials on Physical exercice - moderate intensity
-
Anne Birgitte RabenUniversity of Nottingham; University of Helsinki; Wageningen University; University... and other collaboratorsCompletedObesity | Pre-diabetesSpain, Denmark, Australia, Bulgaria, Finland, Netherlands, New Zealand, United Kingdom
-
University of Geneva, SwitzerlandUniversity Hospital, GenevaCompletedAcute Physical Exercise
-
Brown UniversityNational Institute on Aging (NIA)RecruitingPhysical InactivityUnited States
-
University of GuadalajaraCompleted
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Russo Francesco; Cozzolongo Raffaele; Shahini Endrit; Zappimbulso Marianna; Giannuzzi... and other collaboratorsNot yet recruiting
-
Hasselt UniversityJessa HospitalCompletedInflammation | Low Back PainBelgium
-
University of Sao Paulo General HospitalActive, not recruiting
-
Montreal Heart InstituteCompleted
-
National Taiwan Normal UniversityRecruiting
-
Assistance Publique - Hôpitaux de ParisEurofins BiomnisNot yet recruiting